Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2012; 18(30): 4037-4043
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4037
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4037
Characteristics | Groups | HR (95% CI) | P value |
Univariate analysis | |||
Age (yr) | > 60 vs ≤ 60 | 1.11 (0.52-2.37) | 0.785 |
Gender | F vs M | 1.08 (0.56-2.07) | 0.817 |
PKM2 | Positive vs negative | 2.13 (1.02-4.44) | 0.042 |
T stage | T4 vs T1/2/3 | 6.25 (3.03-12.85) | < 0.001 |
N stage | N3 vs N0/1/2 | 5.70 (2.90-11.22) | < 0.001 |
Stage | III vsI/II | 6.84 (2.83-16.53) | < 0.001 |
Multivariate analysis | |||
PKM2 | Positive vs negative | 2.12 (1.02-4.42) | 0.044 |
Stage | III vsI/II | 6.84 (2.83-16.55) | < 0.001 |
- Citation: Lim JY, Yoon SO, Seol SY, Hong SW, Kim JW, Choi SH, Cho JY. Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer. World J Gastroenterol 2012; 18(30): 4037-4043
- URL: https://www.wjgnet.com/1007-9327/full/v18/i30/4037.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i30.4037